Device Trial Radar · NCT07209852
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
141
Actual
Start
Dec 19, 2025
Primary completion
Aug 31, 2029
Study completion Aug 31, 2029
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Oct 7, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker.
Conditions
- Bradycardia
- Atrioventricular Block
- Sinus Node Dysfunction
- Bundle-Branch Block
Interventions
Pacemaker leadDevice
The pacemaker lead under investigation is a bipolar, steroid-releasing pacemaker electrode with active fixation (IS-1 connection) designed for chronic stimulation and sensing in the right atrium, right ventricle or left bundle branch area (LBBA). In this study, the lead is implanted in the LBBA and connected to a single- or dual-chamber pacemaker. Implantation is performed using a compatible, CE-marked catheter for pacemaker implantation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- LBBA Implant Success RateTime frame: At the time of implant procedure (Day 0).
- Maintenance of Ventricular Synchrony (Paced QRS Duration)Time frame: From implant through 3-year follow-up.
Locations
13 sites in 7 countries. Site status is shown where the registry gives one.
St. Jan-Hospital
Bruges, Belgium
Clinique Saint-Pierre Ottignies-Hospital
Brussels, Belgium
CHRU de Lille
Lille, France
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.